In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that it helped people lower their weight by an average of 12% after 72 weeks.
HARRISBURG, Pa. -- Teenagers and young women who use birth control pills can't blame their tight jeans on the contraceptive, say researchers who have done a long-term study. The study of 66 women who ...
FDA's new voucher could shorten drug review to 1-2 months Lilly's orforglipron targets high-burden chronic condition Analysts predict price erosion due to new market entrants Sept 16 (Reuters) - Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback